Pharmacokinetics of Carnosine

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00721708

Enrollment

Registered

2008-07-24

Start date

2007-04-30

Completion date

2008-07-31

Last updated

2009-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Keywords

histidine dipeptides, carnosine, anserine

Brief summary

The absorption kinetics of dietary carnosine (β-alanyl-L-histidine) will be determined in the healthy adults.

Interventions

DIETARY_SUPPLEMENTpure carnosine

one time dose of pure carnosine (450 mg)

OTHERBeef

one time dose, 150 g of beef

OTHERChicken

One time dose, 150g of chicken breast

OTHERChicken broth

one time dose of chicken broth obtained from 150g of chicken breast

Study design

Intervention model

CROSSOVER

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

40 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy adult * normal hematological parameters, normal serum albumin, normal liver function, normal kidney function

Exclusion criteria

* History of smoking or alcoholism

Design outcomes

Primary

Measure	Time frame
Plasma histidine-dipeptide	0, 30, 60, 100, 180, 240, & 300 min

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026